| Date | Speakers | Seminar Title |
| September 12 |
Assistant Professor Instructor in Pediatrics, Harvard Medical School |
An Update on Health Insurance and Access to Care for Young Adults Post Health Reform: Policy Gains and New Opportunities |
| September 25 |
Associate Professor Harvard Medical School Deparment of Population Medicine Director of Research at Harvard Pilgrim Health Care Institute |
Interrupted Time Series |
| October 10 |
Research Fellow Department of Population Medicine |
Variation in Primary Care Quality Measures: A Multi-Level Analysis |
| October 17 |
Visiting Professor Andalusian School of Public Health |
How Europe is facing the high cost medicines challenge? |
| October 24 |
Harvard School of Public Health Department of Health Policy and Management |
Use of reference-based pricing benefit design to steer patients to low-price imaging providers |
| November 14 |
Medical Oncology Dana Farber Cancer Institute |
Why are Patients with Blood Cancers Less Likely to Receive Quality End-of-Life Care? |
| November 28 |
Assistant Professor of Health Policy at the London School of Economics and Political Science |
Evidence standards for approving cancer medicines in Europe |
| December 12 |
Medical Oncology Dana Farber Cancer Institute |
Rapid innovation in the treatment of lung cancer: Real-world impact |
| January 23 |
Attending Emergency Physician Director, Brigham and Women's Comprehensive Opioid Response and Education Program Assistant Professor, Harvard Medical School |
Addressing the Opioid Epidemic with Policy and Technology |
| January 30 |
Pharmalot Columnist Senior Writer STAT News |
Connecting the dots across the many aspects of US and global drug pricing |
| February 13 |
Associate Professor Department of Pharmacy & Health System Sciences School of Pharmacy Northeastern University |
Food Insecurity among Medicare Beneficiaries, and More |
| March 13 |
Post-doctoral Research Fellow Harvard Pilgrim Health Care Inst. Deptartment of Population Medicine |
Using Claims Data to Study the Intensity of End-of-Life Care in Commercially Insured Patients |
| March 27 |
Associate Professor, Health Policy Ingram Associate Professor of Cancer Research, Vanderbilt University Medical Center |
Improving Access to Prescription Drugs through Policy Change |
| April 3 |
Professor The Dartmouth Institute for Health Policy & Clinical Practice |
Novel Interventions to Modify Physician Decision Making |
| April 10 |
Associate Professor of Medicine and Public Policy Duke Cancer Institute |
Intervening on the Financial Toxicity of Cancer Care |
| April 24 |
Strategic Director Economic Burden of Cancer American Cancer Society |
Financial Hardship Among Cancer Survivors in the United States |
| May 8 |
Saumya Chatrath, PhD Candidate Research Fellow Harvard Pilgrim Health Care Inst. Department of Population Medicine |
Effect of PCP-Specialist Referrals on Spending and Health |
| May 22 |
Harvard Medical School Fellow in General Medicine and Primary Care Harvard Pilgrim Health Care Institute Department of Population Medicine |
Implications of Insulin Costs and Utilization Trends among a Commercially-Insured Diabetes Population |
| June 5 |
Rachele Hendricks-Sturrup, DHsc, MSc, MA Pyle Fellowship Awardee Harvard Pilgrim Health Care Institute Deptartment of Population Medicine |
Opportunities and Challenges to Implementing Genetic Testing for Familial Hypercholesterolemia in the United States |
| June 12 |
Research Fellow Harvard Pilgrim Health Care Institute Department of Population Medicine |
Effect of physicians' knowledge on antibiotics rational use in China's county hospitals |
| June 26 |
Postdoctoral Fellow Harvard Pilgrim Health Care Institute Department of Population Medicine |
Impact of high-deductible health plans on health care utilization and outcomes among patients with chronic obstructive pulmonary disease (COPD) |
| July 17 |
Cecilia Kallberg, MD Research Fellow Harvard Pilgrim Health Care Institute Department of Population Medicine |
Analyzing the immediate and long-term effect of an educational intervention targeting antibiotic prescribing practices of Norwegian GPs, using interrupted time series analysis |
| July 30 |
Affiliate Faculty, Computational Health Informatics Program (CHIP) Visiting Associate Professor of Pediatrics Harvard Medical School |
Can social media research play a practical role in mitigating misinformation and promoting vaccines? |
| August 7 |
Assistant Professor of Health Policy at the London School of Economics and Political Science |
Risk of bias of randomised controlled trials supporting European Medicines Agency approvals of cancer drugs |